Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.

Sridhar SC, Miranti CK.

Oncogene. 2006 Apr 13;25(16):2367-78.

PMID:
16331263
[PubMed - indexed for MEDLINE]
2.

Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.

Zhang XA, He B, Zhou B, Liu L.

J Biol Chem. 2003 Jul 18;278(29):27319-28. Epub 2003 May 8.

PMID:
12738793
[PubMed - indexed for MEDLINE]
Free Article
3.

Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.

Todeschini AR, Dos Santos JN, Handa K, Hakomori SI.

J Biol Chem. 2007 Mar 16;282(11):8123-33. Epub 2007 Jan 10.

PMID:
17215249
[PubMed - indexed for MEDLINE]
Free Article
4.

Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration.

Takahashi M, Sugiura T, Abe M, Ishii K, Shirasuna K.

Int J Cancer. 2007 Nov 1;121(9):1919-29.

PMID:
17621632
[PubMed - indexed for MEDLINE]
5.

Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.

Hui AY, Meens JA, Schick C, Organ SL, Qiao H, Tremblay EA, Schaeffer E, Uniyal S, Chan BM, Elliott BE.

J Cell Biochem. 2009 Aug 15;107(6):1168-81. doi: 10.1002/jcb.22219.

PMID:
19533669
[PubMed - indexed for MEDLINE]
6.

The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.

Zhou B, Liu L, Reddivari M, Zhang XA.

Cancer Res. 2004 Oct 15;64(20):7455-63.

PMID:
15492270
[PubMed - indexed for MEDLINE]
Free Article
7.

Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis.

Miranti CK.

Cell Signal. 2009 Feb;21(2):196-211. doi: 10.1016/j.cellsig.2008.08.023. Epub 2008 Sep 11. Review.

PMID:
18822372
[PubMed - indexed for MEDLINE]
8.

Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.

Xu H, Washington S, Verderame MF, Manni A.

Breast Cancer Res Treat. 2008 Nov;112(2):255-61. Epub 2007 Dec 21.

PMID:
18097746
[PubMed - indexed for MEDLINE]
9.

Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.

Cowell LN, Graham JD, Bouton AH, Clarke CL, O'Neill GM.

Oncogene. 2006 Dec 7;25(58):7597-607. Epub 2006 Jun 26.

PMID:
16799644
[PubMed - indexed for MEDLINE]
10.

Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion.

He B, Liu L, Cook GA, Grgurevich S, Jennings LK, Zhang XA.

J Biol Chem. 2005 Feb 4;280(5):3346-54. Epub 2004 Nov 19.

PMID:
15557282
[PubMed - indexed for MEDLINE]
Free Article
11.

KAI1/CD82, a tumor metastasis suppressor.

Liu WM, Zhang XA.

Cancer Lett. 2006 Aug 28;240(2):183-94. Epub 2005 Nov 2. Review.

PMID:
16260083
[PubMed - indexed for MEDLINE]
12.

BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.

Dai Y, Siemann DW.

Mol Cancer Ther. 2010 Jun;9(6):1554-61. doi: 10.1158/1535-7163.MCT-10-0359. Epub 2010 Jun 1.

PMID:
20515943
[PubMed - indexed for MEDLINE]
Free Article
13.

Integrin-regulated FAK-Src signaling in normal and cancer cells.

Mitra SK, Schlaepfer DD.

Curr Opin Cell Biol. 2006 Oct;18(5):516-23. Epub 2006 Aug 17. Review.

PMID:
16919435
[PubMed - indexed for MEDLINE]
14.

Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion.

Van Slambrouck S, Grijelmo C, De Wever O, Bruyneel E, Emami S, Gespach C, Steelant WF.

Int J Oncol. 2007 Dec;31(6):1501-8.

PMID:
17982677
[PubMed - indexed for MEDLINE]
15.

Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.

Lee HA, Park I, Byun HJ, Jeoung D, Kim YM, Lee H.

Cell Physiol Biochem. 2011;27(5):575-86. doi: 10.1159/000329979. Epub 2011 Jun 15.

PMID:
21691075
[PubMed - indexed for MEDLINE]
16.

Focal complex formation in adult cardiomyocytes is accompanied by the activation of beta3 integrin and c-Src.

Willey CD, Balasubramanian S, Rodríguez Rosas MC, Ross RS, Kuppuswamy D.

J Mol Cell Cardiol. 2003 Jun;35(6):671-83.

PMID:
12788385
[PubMed - indexed for MEDLINE]
17.

Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells.

Herynk MH, Zhang J, Parikh NU, Gallick GE.

J Exp Ther Oncol. 2007;6(3):205-17.

PMID:
17552361
[PubMed - indexed for MEDLINE]
18.

KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.

Malik FA, Sanders AJ, Jiang WG.

Histol Histopathol. 2009 Apr;24(4):519-30. Review.

PMID:
19224455
[PubMed - indexed for MEDLINE]
19.

Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1.

Pongchairerk U, Guan JL, Leardkamolkarn V.

World J Gastroenterol. 2005 Oct 7;11(37):5845-52.

PMID:
16270396
[PubMed - indexed for MEDLINE]
Free Article
20.

Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis.

Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E.

Oncogene. 2011 Mar 31;30(13):1566-76. doi: 10.1038/onc.2010.532. Epub 2010 Nov 29.

PMID:
21119598
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk